Immunoadjuvant Prednisolone Therapy for HIV-Associated Tuberculosis: A Phase 2 Clinical Trial in Uganda

BACKGROUND: Human immunodeficiency virus (HIV)–infected patients with tuberculosis (TB) respond to effective antituberculous therapy, but their prognosis remains poor. Mounting evidence from clinical studies supports the concept of copathogenesis in which immune activation that is triggered by TB an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Mayanja-Kizza, Harriet, Jones-Lopez, Edward, Okwera, Alphonse, Wallis, Robert S., Ellner, Jerrold J., Mugerwa, Roy D., Whalen, Christopher C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2005
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4515766/
https://ncbi.nlm.nih.gov/pubmed/15717259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/427995
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi